HealthEquity, Inc. (NASDAQ:HQY) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the fourteen brokerages that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $110.71.

Several research firms have issued reports on HQY. BTIG Research upped their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. Royal Bank of Canada raised their price target on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research note on Tuesday. Bank of America increased their target price on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. Mizuho started coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price objective on the stock. Finally, JMP Securities increased their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research report on Tuesday.

HealthEquity Stock Up 2.3 %

Shares of HQY stock traded up $2.16 during mid-day trading on Wednesday, hitting $97.55. The company's stock had a trading volume of 392,064 shares, compared to its average volume of 632,161. The stock has a market cap of $8.52 billion, a price-to-earnings ratio of 78.54, a PEG ratio of 1.57 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. HealthEquity has a 52-week low of $62.10 and a 52-week high of $105.82. The business has a 50-day moving average price of $93.11 and a 200 day moving average price of $83.90.

Insider Activity at HealthEquity

In other HealthEquity news, Director Frank Corvino sold 1,247 shares of the business's stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the sale, the director now owns 4,823 shares in the company, valued at $387,093.98. The trade was a 20.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company's stock, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 10,536 shares of company stock valued at $884,517. 2.20% of the stock is owned by company insiders.

Institutional Trading of HealthEquity

Several hedge funds have recently modified their holdings of the company. International Assets Investment Management LLC purchased a new position in HealthEquity in the second quarter worth about $35,000. Paladin Wealth LLC purchased a new position in shares of HealthEquity in the 3rd quarter worth approximately $39,000. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of HealthEquity during the 2nd quarter valued at approximately $73,000. GAMMA Investing LLC raised its holdings in HealthEquity by 57.8% during the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company's stock valued at $77,000 after buying an additional 344 shares during the period. Finally, Quarry LP lifted its position in HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company's stock worth $110,000 after buying an additional 1,089 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.